Skip to main content

Table 4 Integrin expression and overall survival

From: Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer

Integrin

Median OS (95% CI) in months

 
 

Low expression*

High expression

P

Alpha1

39.3 (0.0-97.4)

23.2 (0.0-46.8)

Ns

Alpha2

31.9 (0.0-81.1)

18.4 (0.0-46.4)

Ns

Alpha3

61.8 (21.1-102.5)

16.2 (12.2-20.2)

0.012

Alpha4

17.5 (0.0-50.5)

30.6 (10.1-51.2)

Ns

Alpha5

44.4 (12.1-76.6)

14.7 (9.0-20.4)

0.006

Alpha6

31.9 (15.0-48.8)

36.1 (0.0-73.6)

Ns

Alpha7

31.9 (0.0-63.8)

23.2 (0.0-52.2)

Ns

Alpha11

31.9 (10.0-53.8)

32.8 (0.0-71.5)

Ns

AlphaV

23.2 (0.0-56.1)

30.6 (8.7-52.5)

Ns

Beta1

61.8 (0.0-129.3)

16.1 (13.2-19.0)

0.002

Beta3

61.8 (22.8-100.8)

11.5 (5.4-17.6)

0.013

Beta4

36.1 (20.6-51.5)

16.3 (14.1-18.5)

Ns

Beta5

24.0 (3.5-44.6)

23.2 (0.0-50.8)

Ns

Beta6

32.8 (4.5-61.1)

31.9 (0.0-64.5)

Ns

Beta8

23.2 (3.0-43.4)

36.1 (1.2-71.0)

Ns

  1. *Low = below median, High = above median